Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 65.30
+0.34 (0.52%)
At close: Feb 27, 2026
SHA:688621 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 133.01 | 177.41 | 184.76 | 156.47 | 105.66 | 72.46 |
Depreciation & Amortization | 48.33 | 48.33 | 43.5 | 38.83 | 27.47 | 9.61 |
Other Amortization | 20.16 | 20.16 | 20.48 | 14.01 | 5.91 | 5.23 |
Loss (Gain) From Sale of Assets | - | - | - | 0.04 | -0 | - |
Asset Writedown & Restructuring Costs | 0.31 | 0.31 | 0.71 | 0.21 | 0.52 | 0.08 |
Loss (Gain) From Sale of Investments | 1.82 | 1.82 | -1.29 | -2.62 | -1.68 | -0.42 |
Provision & Write-off of Bad Debts | 41.68 | 41.68 | 57.77 | 18.66 | 10.47 | 3.06 |
Other Operating Activities | 94.29 | 10.31 | 12.68 | 10.64 | 5.12 | 2.32 |
Change in Accounts Receivable | -326.37 | -326.37 | -250.51 | -151.92 | -143.04 | -35.13 |
Change in Inventory | -0.64 | -0.64 | -1.87 | -4.7 | -1.55 | -2.55 |
Change in Accounts Payable | 70.22 | 70.22 | 48.77 | 36.05 | 81.74 | 8.65 |
Change in Other Net Operating Assets | 12.98 | 12.98 | - | - | - | - |
Operating Cash Flow | 71.59 | 32.02 | 92.86 | 103.96 | 88.25 | 62.99 |
Operating Cash Flow Growth | -58.87% | -65.52% | -10.67% | 17.80% | 40.09% | 10.57% |
Capital Expenditures | -7.51 | -30.48 | -72.96 | -103.87 | -84.96 | -27.03 |
Sale of Property, Plant & Equipment | 0 | - | 0 | 0 | 0 | - |
Cash Acquisitions | 96 | - | - | - | - | -4 |
Investment in Securities | -131.5 | -40 | -17 | 89.75 | -192.51 | -5.09 |
Other Investing Activities | 29.48 | 27.86 | 1.29 | 2.62 | 1.68 | 0.42 |
Investing Cash Flow | -13.52 | -42.63 | -88.66 | -11.5 | -275.78 | -35.7 |
Short-Term Debt Issued | - | - | - | 216.17 | 148.01 | 37 |
Long-Term Debt Issued | - | 431.15 | 393.49 | - | - | - |
Total Debt Issued | 492.74 | 431.15 | 393.49 | 216.17 | 148.01 | 37 |
Short-Term Debt Repaid | - | - | - | -153.01 | -33.5 | -25.5 |
Long-Term Debt Repaid | - | -439.6 | -237.61 | -11.72 | -16.19 | -1.5 |
Total Debt Repaid | -406.61 | -439.6 | -237.61 | -164.72 | -49.69 | -27 |
Net Debt Issued (Repaid) | 86.13 | -8.44 | 155.88 | 51.45 | 98.32 | 10 |
Issuance of Common Stock | - | - | - | - | 487.55 | - |
Common Dividends Paid | -37.02 | -38.15 | -55.52 | -26.98 | -1.25 | -1.07 |
Other Financing Activities | -192.17 | -81.14 | -22.56 | 1.75 | -16.15 | -3.4 |
Financing Cash Flow | -143.06 | -127.74 | 77.8 | 26.22 | 568.48 | 5.52 |
Net Cash Flow | -84.99 | -138.35 | 82 | 118.68 | 380.95 | 32.82 |
Free Cash Flow | 64.09 | 1.54 | 19.9 | 0.09 | 3.29 | 35.96 |
Free Cash Flow Growth | -49.43% | -92.28% | 21552.67% | -97.21% | -90.84% | 14.89% |
Free Cash Flow Margin | 6.30% | 0.14% | 2.14% | 0.01% | 0.67% | 10.35% |
Free Cash Flow Per Share | 0.58 | 0.01 | 0.18 | 0.00 | 0.03 | 0.43 |
Cash Income Tax Paid | 52.17 | 65.46 | 41.24 | 32.8 | 12.06 | 17.45 |
Levered Free Cash Flow | -15.53 | -54.66 | -53.26 | -49.86 | -26.78 | 3.66 |
Unlevered Free Cash Flow | -5.37 | -44.59 | -45.65 | -43.79 | -24.55 | 4.31 |
Change in Working Capital | -268.01 | -268.01 | -225.74 | -132.28 | -65.23 | -29.35 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.